Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy-Reference-Cited by-同舟云学术

Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy

Published:2023-12 Issue:23 Volume:15 Page:1233-1236
ISSN:1750-1911
Container-title:Epigenomics
language:en
Short-container-title:Epigenomics

Author:

Jayaseelan Vijayashree Priyadharsini¹^ORCID,Loganathan Kavitha²^ORCID,Pandi Anitha¹^ORCID,Ramasubramanian Abilasha³^ORCID,Kannan Balachander⁴^ORCID,Arumugam Paramasivam⁴^ORCID

Affiliation:

1. Clinical Genetics lab, Centre for Cellular & Molecular Research, Saveetha Dental College & Hospital, Saveetha Institute of Medical & Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu – 600077, India

2. Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital, East Coast Road, Uthandi, Chennai – 600 119. Affiliated to The Tamil Nadu Dr. MGR Medical University, Anna Salai, Guindy, Chennai – 600032, India

3. Department of Oral Pathology, Saveetha Dental College & Hospital, Saveetha Institute of Medical & Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu – 600077, India

4. Centre for Cellular & Molecular Research, Saveetha Dental College & Hospital, Saveetha Institute of Medical & Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu – 600077, India

Publisher

Future Medicine Ltd

Subject

Cancer Research,Genetics

Link

https://www.futuremedicine.com/doi/pdf/10.2217/epi-2023-0293

Reference18 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Secreted protein markers in oral squamous cell carcinoma (OSCC)

3. Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma

4. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

5. Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents